BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 24961866)

  • 1. Current challenges in metastasis: disseminated and circulating tumor cells detection.
    Shahneh FZ
    Hum Antibodies; 2013; 22(3-4):77-85. PubMed ID: 24961866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodology for the Isolation and Analysis of CTCs.
    Costa C; Dávila-Ibáñez AB
    Adv Exp Med Biol; 2020; 1220():45-59. PubMed ID: 32304079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion.
    Wang H; Stoecklein NH; Lin PP; Gires O
    Oncotarget; 2017 Jan; 8(1):1884-1912. PubMed ID: 27683128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disseminated and circulating tumor cells in gastrointestinal oncology].
    Vegas H; André T; Bidard FC; Ferrand FR; Huguet F; Mariani P; Pierga JY
    Bull Cancer; 2012 May; 99(5):535-44. PubMed ID: 22531892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy.
    Paterlini-Bréchot P
    Future Oncol; 2011 Jul; 7(7):849-71. PubMed ID: 21732757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity.
    Gröbe A; Blessmann M; Hanken H; Friedrich RE; Schön G; Wikner J; Effenberger KE; Kluwe L; Heiland M; Pantel K; Riethdorf S
    Clin Cancer Res; 2014 Jan; 20(2):425-33. PubMed ID: 24218516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive antibody-based CTCs detection from peripheral blood.
    Shahneh FZ
    Hum Antibodies; 2013; 22(1-2):51-4. PubMed ID: 24284308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biological significance of circulating tumor cells in cancer.
    Masuda T; Hayashi N; Iguchi T; Ito S; Eguchi H; Mimori K
    Mol Oncol; 2016 Mar; 10(3):408-17. PubMed ID: 26899533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer.
    O'Flaherty JD; Gray S; Richard D; Fennell D; O'Leary JJ; Blackhall FH; O'Byrne KJ
    Lung Cancer; 2012 Apr; 76(1):19-25. PubMed ID: 22209049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications.
    Danova M; Torchio M; Mazzini G
    Expert Rev Mol Diagn; 2011 Jun; 11(5):473-85. PubMed ID: 21707456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status in human breast cancer micrometastasis.
    Alix-Panabières C; Müller V; Pantel K
    Curr Opin Oncol; 2007 Nov; 19(6):558-63. PubMed ID: 17906452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor cells as therapy-related biomarkers in cancer patients.
    Gorges TM; Pantel K
    Cancer Immunol Immunother; 2013 May; 62(5):931-9. PubMed ID: 23314304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cells as promising novel biomarkers in solid cancers.
    Lianidou ES; Strati A; Markou A
    Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
    Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
    Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of circulating tumor cells in breast cancer patients.
    Tao M; Ma D; Li Y; Zhou C; Li Y; Zhang Y; Duan W; Xu X; Wang R; Wu L; Liu H
    Breast Cancer Res Treat; 2011 Aug; 129(1):247-54. PubMed ID: 21512769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumor cells: detection, molecular profiling and future prospects.
    Jacob K; Sollier C; Jabado N
    Expert Rev Proteomics; 2007 Dec; 4(6):741-56. PubMed ID: 18067413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTC clusters in cancer progression and metastasis.
    Fabisiewicz A; Grzybowska E
    Med Oncol; 2017 Jan; 34(1):12. PubMed ID: 28012133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of CTC Clusters in Breast Cancer Metastasis.
    Piñeiro R; Martínez-Pena I; López-López R
    Adv Exp Med Biol; 2020; 1220():93-115. PubMed ID: 32304082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
    Yokobori T; Iinuma H; Shimamura T; Imoto S; Sugimachi K; Ishii H; Iwatsuki M; Ota D; Ohkuma M; Iwaya T; Nishida N; Kogo R; Sudo T; Tanaka F; Shibata K; Toh H; Sato T; Barnard GF; Fukagawa T; Yamamoto S; Nakanishi H; Sasaki S; Miyano S; Watanabe T; Kuwano H; Mimori K; Pantel K; Mori M
    Cancer Res; 2013 Apr; 73(7):2059-69. PubMed ID: 23378342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.